Literature DB >> 26779899

Choroidal thickness changes in obstructive sleep apnea syndrome: a systematic review and meta-analysis.

Miao He1, Xiao Han1, Huiming Wu1, Wenyong Huang2.   

Abstract

PURPOSE: Obstructive sleep apnea syndrome (OSAS) is a common chronic disorder associated with hypoxia and endothelial and vascular dysfunction. Many studies have analyzed choroidal thickness measurements in patients with different severities of OSAS versus normal subjects by optical coherence tomography (OCT), but the results have been inconsistent. Therefore, a meta-analysis was performed to evaluate the choroidal thickness changes in OSAS measured by OCT.
METHODS: Pertinent studies were retrieved by a comprehensive search of PubMed, Embase, Web of Science, and the Cochrane Library from inception to August 2015. For continuous outcomes, the weighted mean difference (WMD) and 95 % confidence interval (CI) were calculated by using a random effects model.
RESULTS: Seven case-control studies were included in the final meta-analysis, containing a total of 784 eyes (558 in the OSAS group and 226 in normal controls). The results showed that subfoveal choroidal thickness (SFCT) was significantly reduced compared with normal controls, with pooled WMD -8.06 (95 % CI -15.72 to -0.41) for mild OSAS, -29.99 (95 % CI -52.40 to -7.58) for moderate OSAS, and -53.72 (95 % CI -88.95 to -18.48) for severe OSAS. Choroidal thickness at 1 mm temporal to the fovea and at 1 mm nasal to the fovea were also significantly lower than those in the normal controls (WMD = -28.94, 95 % CI -43.78 to -14.10 and WMD = -20.90, 95 % CI -36.62 to -5.18).
CONCLUSION: This meta-analysis suggests that choroidal thickness was reduced in OSAS. Considering the non-invasive nature of OCT, OCT could be a useful tool for grading the severity of OSAS.

Entities:  

Keywords:  Choroidal thickness; Meta-analysis; Obstructive sleep apnea syndrome; Optic coherence tomography

Mesh:

Year:  2016        PMID: 26779899     DOI: 10.1007/s11325-015-1306-8

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  34 in total

1.  Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography.

Authors:  Jay Chhablani; Giulio Barteselli; Haiyan Wang; Sharif El-Emam; Igor Kozak; Aubrey L Doede; Dirk-Uwe Bartsch; Lingyun Cheng; William R Freeman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

2.  Comparisons of choroidal thickness of normal eyes obtained by two different spectral-domain OCT instruments and one swept-source OCT instrument.

Authors:  Yukiko Matsuo; Taiji Sakamoto; Takehiro Yamashita; Masatoshi Tomita; Makoto Shirasawa; Hiroto Terasaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-19       Impact factor: 4.799

3.  Choroidal Thickening in Patients with Sleep Apnea Syndrome.

Authors:  Metin Ekinci; Nergiz Hüseyinoğlu; H Hüseyin Çağatay; Sadullah Keleş; Erdinç Ceylan; Gökçen Gökçe
Journal:  Neuroophthalmology       Date:  2014-01-28

4.  Floppy eyelid syndrome as an indicator of the presence of glaucoma in patients with obstructive sleep apnea.

Authors:  MaJesús Muniesa; Manuel Sánchez-de-la-Torre; Valentín Huerva; Marina Lumbierres; Ferran Barbé
Journal:  J Glaucoma       Date:  2014-01       Impact factor: 2.503

5.  Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS Report 1).

Authors:  Juliana L Oréfice; Rogério A Costa; Ingrid U Scott; Daniela Calucci; Fernando Oréfice
Journal:  Acta Ophthalmol       Date:  2012-09-12       Impact factor: 3.761

6.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

7.  Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.

Authors:  Masahiro Okamoto; Toyoaki Matsuura; Nahoko Ogata
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2015-01       Impact factor: 1.300

8.  Evaluation of choroidal thickness using spectral-domain optical coherence tomography in patients with severe obstructive sleep apnea syndrome: a comparative study.

Authors:  Aylin Karalezli; Fatma Corak Eroglu; Tulay Kivanc; Rusina Dogan
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

9.  Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea.

Authors:  K Palombi; E Renard; P Levy; C Chiquet; Ch Deschaux; J P Romanet; J L Pépin
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more
  14 in total

1.  Structural and functional retinal abnormalities in type 2 diabetes with obstructive sleep apnea.

Authors:  Rajiv Raman; Sangeetha Srinivasan; Ramakrishnan Nagarajan
Journal:  Sleep Breath       Date:  2016-04-26       Impact factor: 2.816

2.  Quantitative evaluation of retinal microvascular circulation in patients with obstructive sleep apnea-hypopnea using optical coherence tomography angiography.

Authors:  Yi Cai; Guo-Sheng Sun; Long Zhao; Fang Han; Ming-Wei Zhao; Xuan Shi
Journal:  Int Ophthalmol       Date:  2020-08-02       Impact factor: 2.031

3.  Evaluation of choroidal thickness in children with adenoid hypertrophy.

Authors:  Taliye Cakabay; Selin Üstün Bezgin; Sadık Etka Bayramoglu; Nihat Sayin; Murat Kocyigit
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-01-08       Impact factor: 2.503

4.  Evaluation of retinal vessel density and foveal avascular zone measurements in patients with obstructive sleep apnea syndrome.

Authors:  Mustafa Çolak; Dilay Özek; Kürşat Murat Özcan; Fakih Cihat Eravcı; Süleyman Emre Karakurt; Mehmet Fatih Karakuş; Özlem Evren Kemer
Journal:  Int Ophthalmol       Date:  2021-01-08       Impact factor: 2.031

5.  Effect of obstructive sleep apnoea syndrome and continuous positive airway pressure treatment on choroidal structure.

Authors:  Meltem Guzin Altinel; Hasim Uslu; Ayse Yagmur Kanra; Orhan Dalkilic
Journal:  Eye (Lond)       Date:  2021-10-07       Impact factor: 4.456

6.  Optical coherence tomography angiography and Humphrey visual field in patients with obstructive sleep apnea.

Authors:  Arash Davanian; Lindsay Williamson; Caitlen Taylor; Abigail Harrover; Kathryn Bollinger; Bashir Chaudhary; Varsha Taskar; Tae Jin Lee; Yuhan Liu; Qingxia Chen; Dennis M Marcus
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

7.  Thinning of the inner and outer retinal layers, including the ganglion cell layer and photoreceptor layers, in obstructive sleep apnea and hypopnea syndrome unrelated to the disease severity.

Authors:  Soner Guven; Deniz Kilic; Omer Faruk Bolatturk
Journal:  Int Ophthalmol       Date:  2021-06-25       Impact factor: 2.031

8.  Associations of sleep apnoea with glaucoma and age-related macular degeneration: an analysis in the United Kingdom Biobank and the Canadian Longitudinal Study on Aging.

Authors:  Xikun Han; Samantha Sze-Yee Lee; Stuart MacGregor; David A Mackey; Nathan Ingold; Nigel McArdle; Anthony P Khawaja
Journal:  BMC Med       Date:  2021-05-11       Impact factor: 11.150

9.  Posterior segment assessment in patients with obstructive sleep apnea syndrome.

Authors:  Bekir Küçük; Ender Sırakaya; Şenol Delibaş
Journal:  Sleep Breath       Date:  2019-04-04       Impact factor: 2.655

10.  To Evaluate the Effect of Chronic Obstructive Pulmonary Disease on Retinal and Choroidal Thicknesses Measured by Optical Coherence Tomography.

Authors:  Sait Alim; Helin Deniz Demir; Ayşe Yilmaz; Selim Demir; Alper Güneş
Journal:  J Ophthalmol       Date:  2019-10-08       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.